Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Origen Therapeutics Inc.

www.origentherapeutics.com

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Transgenics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Origen Therapeutics Inc.
  • Senior Management
  • Robert Kay, PhD, CEO
    Karen Chapman, PhD, VP, Corp. Dev.
    Phil Leighton, Dir., Research
  • Contact Info
  • Origen Therapeutics Inc.
    Phone: (650) 827-0200
    1450 Rollins Rd.
    Burlingame, CA 94010-2307
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register